NeoGenomics
270 hedge funds and large institutions have $1.82B invested in NeoGenomics in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 75 increasing their positions, 94 reducing their positions, and 23 closing their positions.
449% more call options, than puts
Call options by funds: $12.3M | Put options by funds: $2.24M
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
4% more funds holding
Funds holding: 259 → 270 (+11)
5% more capital invested
Capital invested by funds: $1.74B → $1.82B (+$82.2M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.71% less ownership
Funds ownership: 98.42% → 96.7% (-1.7%)
20% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 94
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$18.9M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$11.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.78M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$6.42M |
| 5 |
Goldman Sachs
New York
|
+$6.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$29.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.3M |
| 3 |
JP Morgan Chase
New York
|
-$12.2M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$11M |
| 5 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
-$5.02M |
NEO Hedge Fund Activity: Q3 2024 in Review
270 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2024, worth a combined $1.82B — up 4.7% from $1.74B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new NEO positions and 23 closed out — a net gain of 13 holders — while 75 added to existing stakes and 94 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $18.9M. The largest seller was Brown Advisory, cutting an estimated $29.5M.
- 270 institutional investors held NeoGenomics (NEO) as of Q3 2024, up from 259 in Q2 2024.
- Funds reported $1.82B of NeoGenomics stock for Q3 2024, up 4.7% quarter-over-quarter.
- 36 funds opened new NeoGenomics positions in Q3 2024 and 23 closed out, a net change of +13 holders.
- The largest NeoGenomics buyer in Q3 2024 was Loomis, Sayles & Company, an estimated $18.9M added.
- The largest NeoGenomics seller in Q3 2024 was Brown Advisory, an estimated $29.5M sold.
Based on aggregated 13F filings for Q3 2024.